New coronavirus variant could be problematic for vaccines, a second study in two days suggests
From CNN s Senior Medical Correspondent Elizabeth Cohen
As researchers around the world race to see if new coronavirus variants will pose a problem for the vaccines, a second study in two days says a variant from South Africa could possibly do just that.
The variant was first spotted in South Africa in October and has now been found in more than a dozen countries.
In both studies, the work was done in the lab and not in people, so more research is needed to gauge the true threat of the new variant.
Bolivia has registered Sputnik V vaccine based on Russian clinical trial data
Sputnik V has been registered under the emergency use authorization procedure
Moscow, January 6, 2021 –
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the registration of the Russian Sputnik V vaccine against coronavirus by State Agency for Medicines and Health Technologies (Agencia Estatal De Medicamentos Y Tecnologías En Salud, AGEMED) of the Plurinational State of Bolivia.
The vaccine was registered under the emergency use authorization procedure and was approved by AGEMED based on the results of Phase III clinical trials in Russia, without additional trials in Bolivia. Sputnik V was registered by Argentina’s regulator ANMAT under the same procedure on December 23, 2020.
RDIF agrees to supply 2.6 million doses of Russian Sputnik V coronavirus vaccine to Bolivia RDIF 286 RDIF 31 December 2020 17:10 The Russian Direct Investment Fund (RDIF, Russia s sovereign wealth fund) and the Health Supply Centre (Central de Abastecimiento y Suministros de Salud, CEASS) of the Plurinational State of Bolivia announce the agreement to supply the country with 2.6 million doses of Sputnik V, the world s first registered vaccine against coronavirus. The signing ceremony took place in a video-conference format today and the Constitutional President of the Plurinational State of Bolivia, Luis Alberto Arce Catacora, Vice President David Choquehuanca Céspedes, the Minister of Health and Sports of Bolivia, Edgar Pozo Valdivia, General Director of the CEASS, Victor Hugo Aguilar Frias, Deputy Director of the Latin American Departm
Russia to supply Bolivia with 2.6 million doses of Sputnik V
The Russian vaccine is based on a well-researched human adenoviral vector platform, RDIF CEO said
(REUTERS)
Share Via
Read Full Story
Russia said on Wednesday that it would supply 2.6 million doses of Sputnik V, the first vaccine registered against novel coronavirus, to Bolivia. The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and the Health Supply Centre (Central de Abastecimiento y Suministros de Salud, CEASS) of the Plurinational State of Bolivia announce the agreement to supply the country with 2.6 million doses of Sputnik V, the official statement read.